about
Cannabinoids as therapeutic agents in cancer: current status and future implicationsCannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effectAppraisals of Bangladeshi Medicinal Plants Used by Folk Medicine Practitioners in the Prevention and Management of Malignant Neoplastic DiseasesThe Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humansCannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.Towards the use of non-psychoactive cannabinoids for prostate cancerIntegrating cannabis into clinical cancer care.Critical appraisal of the potential use of cannabinoids in cancer management.Intercellular adhesion molecule 1: recent findings and new concepts involved in mammalian spermatogenesisCannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy.Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.The evolving role of the endocannabinoid system in gynaecological cancer.Marijuana: A Fifty-Year Personal Addiction Medicine Perspective.Cannabidiol Reduces Leukemic Cell Size - But Is It Important?In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy.Regulation of human glioblastoma cell death by combined treatment of cannabidiol, γ-radiation and small molecule inhibitors of cell signaling pathways.The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy.Cannabidiol, a novel inverse agonist for GPR12.Medical marijuana in pediatric oncology: A review of the evidence and implications for practice.VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis.Targeting Mitochondrial Ion Channels to Fight CancerCannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
P2860
Q26866298-F2097C92-F7C9-4105-84AA-7F2812C7AF77Q28534561-03D22F82-F33A-4787-812D-BF5022F197E1Q28828586-76DCC9C4-5A8E-40D5-B80A-A24F1781DFFDQ33623423-9D8D8B2C-A65B-4138-9F43-7EF810015450Q34441093-7A2BAD6B-046E-4D00-9EDA-723D770DDF42Q34669534-28D634F0-B916-4458-866A-B2B945EBBC92Q35287890-6AAE5031-3070-447E-996A-3019B3DE68CEQ35665889-9F3F2876-6C6B-4252-B268-60A027FBE1AEQ35707221-C5A2DEC6-D5E2-4EE3-9A3F-E02A9FBC5BE6Q36077672-62A2EF56-72B0-4088-A034-5B2D5E79371DQ36347143-D5BD088D-60B3-43B1-A096-5F73E1C6FA4DQ36603185-90A211EC-A133-4116-A97E-D1E23D21FD60Q36685151-D71E80A9-FE48-4A83-BC23-DFC4DA8339D7Q37164208-8BC3317E-42B5-40C7-B818-6E268B9EAE8AQ37578039-2579FE6A-6BED-4D11-B6EB-0A82FE81ABB5Q37671286-6ED82E50-0F22-4608-B7B7-0A511D4EC909Q38351132-6BF143D9-DBDF-4839-A281-749794CC08CBQ38469671-D537DCA3-4F01-462F-8C26-1D3E5904F071Q38693519-4613A511-3B7B-4531-996E-D4E362254C7CQ38708381-9FB40079-0734-4A23-80F9-13017993D62FQ38990460-D46A20C3-3C65-4431-AFAE-2FCF39912C9DQ39431492-DC619719-5C08-40E3-9671-3CB96A500D4BQ41560648-7E105765-6AD8-4CA2-B36B-2BD7427F56AFQ45410310-2BC098A1-5B6D-4166-A79F-07C4DF720179Q47235768-AC5FE7D8-33AA-4B78-B86A-E332B0B2B74CQ47827933-940E0C53-4FBB-4F22-94AC-534B673F97E7Q47941145-606FB023-81CE-4126-AF57-35F071F91CFEQ55129102-79ED41BA-8776-4CD2-99A5-6F6E9D9DDF76Q57175954-B6E827A9-68BB-48EA-A01E-1BEF9304A09FQ58785789-6CE5077F-7D58-4104-B5EA-27C39DE44C11
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cannabidiol as potential anticancer drug.
@ast
Cannabidiol as potential anticancer drug.
@en
Cannabidiol as potential anticancer drug.
@nl
type
label
Cannabidiol as potential anticancer drug.
@ast
Cannabidiol as potential anticancer drug.
@en
Cannabidiol as potential anticancer drug.
@nl
prefLabel
Cannabidiol as potential anticancer drug.
@ast
Cannabidiol as potential anticancer drug.
@en
Cannabidiol as potential anticancer drug.
@nl
P2093
P2860
P1476
Cannabidiol as potential anticancer drug.
@en
P2093
Daniela Parolaro
Marta Solinas
Paola Massi
P2860
P304
P356
10.1111/J.1365-2125.2012.04298.X
P407
P577
2013-02-01T00:00:00Z